Quentin McCubbin

Quentin McCubbin is a highly experienced professional in the field of chemistry and pharmaceuticals, currently serving as Chief Technical Officer at Engrail Therapeutics since November 2023. Prior to this role, Quentin held the position of Chief Manufacturing Officer at Frequency Therapeutics from January 2021 to November 2023. Earlier experience includes serving as Head Of Technical Operations at Cerevel Therapeutics and various roles at Takeda, including Vice President and Global Head Of Chemical Development Laboratories. Quentin’s career began at Lovesgrove Research as a Senior Chemist, followed by a position at Cambridge Discovery Chemistry. Educational credentials include a PhD in Chemistry from Monash University and a postdoctoral fellowship at Imperial College London.